Markets
BSE See NSE See 47,705.80
-243.62 (-0.51%)
IPCA LABORATORIES: PROSPERITY LIES IN GOOD HEALTH

IPCA LABORATORIES: PROSPERITY LIES IN GOOD HEALTH

Print

Globally, India is known to be the largest provider of generic drugs. The Indian pharmaceutical sector supplies over 50 per cent of global demand for various vaccines with 40 per cent of generic demand in the US and 25 per cent of all the medicine in the UK. At such a juncture, Ipca Laboratories is well-poised to derive maximum mileage with its impressive product portfolio and research and development expertise   

To read the entire article, you must be a DSIJ magazine subscriber.

 

Comments are only visible to subscribers.

DSIJ Mindshare

Caplin Point subsidiary gets USFDA approval for Milrinone Lactate injection

Ganesh V / Article rating: 4.5

Caplin Point Laboratories Limited announced on Monday after the market hours that its subsidiary company, Caplin Steriles Limited, has been granted final approval from United States Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) Milrinone Lactate injection. 

1345Last